Is WTW a Buy? What to Consider in 2026

Last updated July 2026

Short answer

The bull case for Willis Towers Watson (WTW) rests on Risk and Broking momentum: The Risk and Broking segment has been WTW's growth leader, posting mid-to-high single-digit organic growth as the firm invests in specialty broking and hires producers. Revenue (TTM) is ~$9.9B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: WTW is a mature business with mid-single-digit organic growth, so any deceleration in Risk and Broking or benefits demand can pressure a valuation that already assumes steady execution. Whether WTW is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.

Willis Towers Watson (Nasdaq: WTW) is a global professional services firm built around two core lines: Risk and Broking (insurance brokerage, risk advisory, and reinsurance-adjacent services) and Health, Wealth and Career (employee benefits, retirement and pension consulting, compensation, and investment advice). The Health, Wealth and Career segment is the larger contributor at roughly 60% of revenue, while Risk and Broking has been the faster-growing engine. The company earns recurring fees and commissions from corporate clients ranging from small businesses to multinationals, which gives revenue a relatively stable, subscription-like character. The investment picture is one of a steady compounder. WTW generated about $9.7 billion of revenue in 2025 and returned to strong profitability after a weak prior year, with adjusted EBITDA margins in the high-20s percent range and consistent share buybacks. Growth is mid-single-digit organic, so the return case rests on margin expansion, capital returns, and modest topline gains rather than rapid revenue growth. It sits behind Marsh McLennan and Aon in scale, which frames it as the smaller of the big-four brokers with room to close a margin gap.

What's the case for buying WTW?

1. Risk and Broking momentum

The Risk and Broking segment has been WTW's growth leader, posting mid-to-high single-digit organic growth as the firm invests in specialty broking and hires producers. Insurance brokerage benefits from firm-to-rising insurance pricing and the non-discretionary nature of coverage. Continued share gains here are central to the growth story.

2. Margin expansion

Management has prioritized operating margin improvement, and recent quarters showed adjusted operating margin and EBITDA margin ticking higher year over year. Because WTW's margins have historically trailed larger peers like Marsh McLennan and Aon, there is a visible runway to close that gap through cost discipline and mix shift toward higher-margin advisory work.

3. Capital returns and cash generation

WTW throws off substantial free cash flow and has been an aggressive buyer of its own stock, repurchasing hundreds of millions of dollars of shares per quarter alongside a growing dividend. Shrinking the share count amplifies per-share earnings growth even when revenue growth is modest, a meaningful lever for total return.

4. Health, Wealth and Career demand

The larger HWC segment rides structural demand for benefits consulting, retirement and pension advice, and workforce and compensation strategy. Complex regulation, aging workforces, and rising healthcare costs keep employers reliant on advisers, supporting recurring, mid-single-digit organic growth in the base business.

What are the risks to WTW?

WTW is a mature business with mid-single-digit organic growth, so any deceleration in Risk and Broking or benefits demand can pressure a valuation that already assumes steady execution. Much of the earnings-per-share growth depends on margin gains and buybacks rather than revenue, which limits the cushion if margins stall. The firm is smaller and historically lower-margin than Marsh McLennan and Aon, leaving it more exposed to competitive pressure on talent and pricing. Insurance brokerage revenue is sensitive to insurance pricing cycles and macro conditions that affect client budgets and payrolls. Large advisory and consulting firms also carry integration, litigation, and reputational risks tied to complex client engagements.

How is WTW valued? (as of July 2026)

Price
$295.11
Market cap
$27.87B
P/E (TTM)
17.33
Forward P/E
13.31
Price / book
3.49
Beta
0.44
52-week range
$240.61 to $352.79

Snapshot for WTW as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Revenue (TTM): ~$9.9B
  • Net income (FY2025): ~$1.6B
  • Market cap: ~$27B
  • Forward P/E: ~15x
  • Dividend yield: ~1.3%
  • Adjusted EBITDA margin: ~27%

As of July 2026 WTW traded around $289 per share with a market cap near $27 billion and a forward P/E under 15, a moderate multiple for a stable advisory and broking franchise. Full-year 2025 revenue was about $9.7 billion with net income around $1.6 billion, and Q1 2026 revenue grew roughly 8% to $2.41 billion with adjusted EPS up 19%. The stock is valued more like a steady cash compounder than a high-growth name.

How do you decide if WTW is a buy?

Rather than asking whether WTW is a buy in the abstract, it tends to help to answer four questions:

  • Thesis: do you believe the case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold WTW indirectly through an index or sector ETF before adding more.

For the full picture, see the WTW stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about WTW against your real portfolio and see your actual exposure before deciding.

The bottom line on WTW

The bottom line: Willis Towers Watson's story right now is Risk and Broking momentum, with revenue (ttm) at ~$9.9B. If you believe that narrative continues, the call is about sizing WTW sensibly and checking overlap with what you own; if you doubt it (the risk: wTW is a mature business with mid-single-digit organic growth, so any deceleration in Risk and Broking or benefits demand can pressure a valuation that already assumes steady execution.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.

More on WTW

Build a basket around WTW with Walnut

Use Willis Towers Watson as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.

FAQ

Is WTW a good stock to buy right now?

+

The case for Willis Towers Watson right now is Risk and Broking momentum, with revenue (ttm) at ~$9.9B. If you believe that thesis holds, WTW is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is wTW is a mature business with mid-single-digit organic growth, so any deceleration in Risk and Broking or benefits demand can pressure a valuation that already assumes steady execution. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.

What does Willis Towers Watson do?

+

Willis Towers Watson (Nasdaq: WTW) is a global professional services firm built around two core lines: Risk and Broking (insurance brokerage, risk advisory, and reinsurance-adjacen

What are the main risks of WTW?

+

WTW is a mature business with mid-single-digit organic growth, so any deceleration in Risk and Broking or benefits demand can pressure a valuation that already assumes steady execution. Much of the earnings-per-share growth depends on margin gains and buybacks rather than revenue, which limits the cushion if margins stall. The firm is smaller and historically lower-margin than Marsh McLennan and Aon, leaving it more exposed to competitive pressure on talent and pricing. Insurance brokerage revenue is sensitive to insurance pricing cycles and macro conditions that affect client budgets and payrolls. Large advisory and consulting firms also carry integration, litigation, and reputational risks tied to complex client engagements.

What does Willis Towers Watson (WTW) do?

+

WTW is a global advisory, broking, and solutions company. It sells insurance brokerage and risk advice through its Risk and Broking segment and employee benefits, retirement, compensation, and investment consulting through its Health, Wealth and Career segment.

How does WTW make money?

+

It earns recurring fees and commissions from corporate clients for brokerage and advisory services. Revenue is relatively stable because insurance and benefits programs are ongoing, non-discretionary needs for most employers, giving the business a subscription-like character.

Is WTW profitable?

+

Yes. WTW generated about $9.7 billion of revenue in 2025 with net income near $1.6 billion and adjusted EBITDA margins in the high-20s percent range. Q1 2026 showed continued revenue growth and margin expansion year over year.

Who are WTW's main competitors?

+

Its closest rivals are the other large global brokers Marsh McLennan and Aon, both larger by revenue, plus Arthur J. Gallagher. In benefits consulting it competes with Mercer, Aon's health and wealth practices, and specialized retirement and compensation firms.

Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell WTW; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.

Related stocks

    Is WTW a Buy? What to Consider in 2026, Walnut